Purpose: The aim of the present study was to investigate the influence of smoking on different parameters such as oocyte count, embryo score, and basal hormone values within the scope of in vitro fertilization-embryo transfer (IVF-ET
(P = 0.0033) lower than those of nonsmokers. According to the stimulation protocol used, we found the following results. Smoking patients in group I showed a significantly (P = 0.023) lower embryo score and produced fewer oocytes (P = 0.0113), with fewer of them being fertilized (P =
0
INTRODUCTION
The association between smoking and female infertility has been discussed in many studies. Jick et al. (1) observed a shorter reproductive phase, an earlier onset of menopause, and a reduction in fertility among smokers in comparison with nonsmokers. Baird and Wilcox (2) and Howe et al. (3) confirmed these results. Feichtinger et al. showed, in their meta-analysis (4), a significantly lower pregnancy rate among smokers. Remmer and Schindler (5) reported a higher spontaneous abortion rate and premature birth rate and, in addition, an influence on fetal development.
Under controlled conditions in vitro fertilizationembryo transfer (IVT-ET) offers the possibility to investigate the influence of nicotine and other tobacco contents on biological factors. The purpose of this study was to accurately analyze oocyte quality, hormone parameters of the pituitary system, stimulation of ovaries, endometrium, oocytes, fertilization rate, and implantation.
METHODS
In this retrospective study the IVF database of our institute was used to obtain information on the smoking status of women undergoing IVF-ET. Beginning hormonal stimulation in the scope of IVF-ET, the patients were classified as nonsmokers or smokers, the latter according to their habits: light (1-9 cigarettes per day), medium (10-20 cigarettes per day), and heavy (more than 20 cigarettes per day) smokers. The height and weight of the patients were recorded and the following data were obtained in every group: follicle-stimulating hormone (FSH), luteinizing hormone (LH), dehydroepiandrosterone sulfate (DHEAS), human prolactin (HPRL), and 17-B-estradiol (E 2 ) on the second or third day of the cycle.
According to the stimulation protocols, we obtained three groups. Group I (332 patients) received combined stimulation with clomiphene citrate and human menopausal gonadotropin (hMG) (8) . The patients in group II (433 patients) were treated with an "ultrashort flareup protocol" (6) with the gonadotropin releasing hormone agonist (GnRHa) Buserelin and pure folliclestimulating hormone (FSH). Group III (73 patients) was stimulated with a long downregulation protocol (GnRHa-FSH) (7) .
The quality of the embryo, the so-called "embryo score," was assessed prior to ET according to the method of Steer et al. (9) : Grade 4, equal-sized symmetrical blastomeres; Grade 3, uneven blastomeres with < 10% fragmentation; Grade 2, 10-50% blastomeric fragmentation; and Grade 1, >50% blastomeric fragmentation or pronucleate single-cell embryos. The morphological grade of the embryo was then multiplied by the number of blastomeres.
Additional variables were the number of oocytes recovered during follicle aspiration, pathological fertilization (three or more pronuclei, no further development), and those oocytes which were used for embryo transfer and those used for freezing (Grade 4).
Statistical analysis was performed using a standardized computer program (Stat View; Abacus Concepts, USA). The following tests were used: chi-square test, Student's t test, and analysis of variance (ANOVA).
RESULTS
Eight hundred thirty-four women undergoing IVF-ET were classified into nonsmokers (75.97%) and smokers (24.03%) on the basis of questionnaires. Smoking patients (33.27 ± 4.93 years) were significantly (P = 0.0195) younger than nonsmoking ones (34.19 ± 5.33). Height and weight were not significantly different between nonsmokers and smokers. The reasons for sterility and indication for IVF-ET were equally distributed in both groups.
Analysis of the hormone parameters showed significant differences between smokers and nonsmokers ( Fig. 1) . The mean baseline LH levels (days 2-3) were significantly (P = 0.0001) higher in smokers (5.26 ± 3.35 mU/ml) versus nonsmokers (3.89 ± 2.35 mU/ ml). A significantly (P = 0.0033) lower basal HPRL was measured in smokers (15.96 ± 7.08 ng/ml) versus nonsmokers (19.23 ± 10.69 ng/ml). A significant (P = 0.0039) difference was found in the mean DHEAS levels in women who smoked (1.38 ± 0.71 (Ug/ml) versus in those who did not (1.13 ± 0.72 Ug/ ml). Basal E 2 was significantly (P = 0.0112) higher in smokers (39.11 ± 43.37 pg/ml) than in nonsmokers (30.55 ± 18.85 pg/ml). However, mean basal FSH levels showed no statistical difference (9.56 mU/ml ± 4.42 in smokers and 9.36 mU/ml ± 5.95 in nonsmokers).
Among smokers there was a slight trend toward a lower oocyte count at oocyte recovery (6.44 ± 3.68 in smokers versus 6.99 ± 4.09 in nonsmokers). In terms of the number of pathologically fertilized oocytes as well as those which were suitable for cryopreservation, we found no significant differences between the two groups ( Table I ). The quality of fertilized oocytes, i.e., the embryo score, was significantly (P = 0.0379) lower in smokers (38.89 ± 21.56) than in nonsmokers (43.08 ± 24.24). The cancellation rate was 17.6% among patients who smoked and 14.5% among nonsmokers, for various reasons (e.g., lack of follicle growth, a lower oocyte count, i.e., "low response"). There was a slightly higher pregnancy rate in nonsmokers (30.55%) versus smokers (24.30%; not significant), but this has been reported for the same patient material elsewhere (4). The abortion and ectopic pregnancy rates were not different between the two groups.
According to the stimulation protocol used, we obtained the following results. Group I (Table II) , treated with clomiphene citrate and hMG, consisted of 245 nonsmokers and 87 smokers. Analysis of the hormone parameters showed significant differences between smokers and nonsmokers. The mean baseline LH level (days 2-3) was significantly (P = 0.0002) higher in smokers (5.59 ± 2.79 mU/ml) versus nonsmokers (4.00 ± 2.45 mU/ml). A significantly (P = 0.0031) lower basal HPRL was measured in smokers (16.32 ± 6.67 ng/ml) versus nonsmokers (21.29 ± 11.31 ng/ml). However, mean basal FSH levels, DHEAS, and E 2 showed no statistical difference between smokers and nonsmokers. Among smokers a significantly (P = 0.0113) lower number of oocytes was retrieved (5.14 ± 2.53 versus 6.14 ± 3.36), a significantly (P = 0.0072) lower number of oocytes was fertilized (3.33 ± 2.02 versus 4.18 ± 2.65), and significantly (P = 0.0067) fewer of them were suitable for embryo transfer (2.10 ± 0.88 versus 2.39 ± 0.84). The quality of fertilized oocytes, i.e., the embryo score was also significantly (P = 0.023) lower in smokers (36.78 ± 22.20) than in nonsmokers (43.53 ± 23.27). In terms of the number of pathologically fertilized oocytes as well as those which were suitable for cryopreservation, we found no significant difference between nonsmokers and smokers. The cancellation rate because of different reasons was higher among patients who smoked (20.91%) than among nonsmokers (13.43%; P = 0.0922). Furthermore, the thickness of the endometrium on the day of ET was significantly (P = 0.0366) higher in nonsmokers. We found no significant difference in the pregnancy rate: 35.10% of nonsmokers and 29.89% of smokers became pregnant (Table III) .
Group II (Table II) , treated with an "ultrashort protocol," included 328 nonsmokers and 105 smokers. Among the hormonal parameters assessed, the basal E 2 levels (44.88 ± 63.28 versus 28.8 ± 17.74 pg/ml) as well as the LH values (4.99 ± 3.93 versus 3.81 ± 2.29 mU/ml) were significantly elevated in smoking patients (P = 0.0089 for E 2 versus P = 0.0092 for Other recorded parameters (number of recovered, normal and pathologically fertilized, cryopreserved, and transferred oocytes, embryo score, and endometrium thickness) showed no significant differences in comparisons between smokers and nonsmokers. Finally, we did not find a significantly different pregnancy rate (26.36% in smokers versus 25.42% in nonsmokers) or cancellation rate (15.45% in smokers versus 16.20% in nonsmokers) (Table III) .
Group III (Table II) consisted of 61 nonsmokers and 12 smokers stimulated with the long protocol. While FSH, LH, E 2 , and DHEAS levels were not significantly altered in smokers, HPRL showed a trend (P = 0.0535) toward lower values (9.23 ± 2.94 in smokers versus 19.34 ± 9.52 ng/ml in nonsmokers). Sixteen and sixtyseven hundredths percent of smoking patients and 31.15% of nonsmokers became pregnant (P = 0.5066). While the cancellation rate was 8.96% in nonsmokers in this stimulation group, no cycle had to be cancelled in smokers (P = 0.289) (Table III) .
There were no differences whatsoever when patients were again subdivided according to the number of cigarettes smoked (light, medium, and heavy smokers), but in this calculation the groups had become quite small.
DISCUSSION
Smoking is emerging as an increasingly important factor in IVF-ET. This is because smokers constitute a considerable proportion of patients who undergo IVF-ET and the consumption of tobacco is steadily increasing, especially among younger women. This epidemiologic trend was also observed in our studysmokers were significantly younger than nonsmoking women.
Smoking influences the reproductive system and therefore, apperently, IVF-ET treatment and its hormonal parameters. In our overall results the E 2 levels determined on the second or third day of the menstrual cycle were significantly higher. One explanation for this phenomenon is offered by Bodis et al. (10) , who describe the effect of nicotine on human follicular cells in vitro. The authors report that nicotine caused a dosedependent increase in E 2 secretion. Elevated E 2 levels may indicate an impaired ovarian response and result in a higher cancellation rate and a lower oocyte yield (11) . A further interesting observation was that prolactin levels were generally significantly lower among smokers (especially in Group I, and Group III showed a trend toward decreased levels). This was confirmed by Berta et al. (12) , who postulated that nicotine causes a central release of dopamine and thus inhibits the secretion of prolactin. Physiologically, the enhanced prolactin level after parturition has a modulating effect on the FSH/LH mechanism, which prevents a subsequent early pregnancy (13) . Therefore, a lower prolactin level should theoretically have a positive effect on fertility rates. However, it was reported in the literature (14) that fertility may also be influenced negatively when prolactin levels are too low. We therefore believe that the influence of HPRL on IVF parameters must be studied further.
Furthermore, we found altered results concerning oocyte number and quality depending on smoking status and the stimulation protocol used. In Group I a lower oocyte count and a poor oocyte quality, manifested by a lower embryo score, were recorded. Premature atresia or damaged oocytes may be caused by several harmful substances (rhodanite, cotinine, cadmium) that accumulate in the follicular fluid of smokers.
Trapp et al. (15) proved the existence of rhodanite, a substance found in tobacco, in the follicular fluid. This was an indication of the number of cigarettes consumed. Zenzes et al. (16) reported a significant, dose-dependent increase in cadmium levels in the follicular fluid of smokers. They suspect that the accumulation of heavy metal in tobacco impairs the normal course of meiotic cell division by inhibiting the spindle apparatus function of maturing oocytes and causes chromosomal abnormalities and a lower number of oocytes that reach full maturity. In a subsequent study Zenzes et al. (17) observed a correlation between the number of cigarettes smoked per day and elevated cotinine levels in the follicular fluid and serum of smoking patients.
We also attempted to recalculate our data according to the number of cigarettes smoked (light, medium, or heavy), but no statistical differences could be shown among these groups. This however, could be due partly, to the fact that the calculated numbers became quite small in some groups. The influence of smoking on pregnancy rates has been controversially discussed in various studies. A meta-analysis recently published by Feichtinger et al. (4) , which reports the authors' own data as well as the results of seven other important publications, mentions significant differences between the two groups. The authors performed a statistical meta-analysis of 2314 first cycles of IVF-ET treatment, showing that the pregnancy rate among nonsmokers (21%) was significantly higher than that among smokers (14%).
In conclusion the results of the present study did not demonstrate significantly impaired pregnancy or cancellation rates in smoking patients. However, we found significantly altered hormonal parameters, a negatively influenced oocyte count, fertilization rate, and embryo score, particularly in the group stimulated with a combined clomiphene citrate/hMG protocol. Therefore we might consider using only GnRHa protocols for smoking patients.
Additionally we advise our patients to abandon smoking before an IVF-ET treatment, in view of earlier results (4, 18, 19, 20, 23) as well the complex effects of smoking on hormonal parameters and oocyte number and quality.
